Literature DB >> 22052886

Companion drugs for amphotericin B in cryptococcal meningitis: flucytosine, fluconazole, or...Nothing?

John Bennett.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22052886      PMCID： PMC3246874          DOI： 10.1093/cid/cir758

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  7 in total

1.  Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial.

Authors:  Annemarie E Brouwer; Adul Rajanuwong; Wirongrong Chierakul; George E Griffin; Robert A Larsen; Nicholas J White; Thomas S Harrison
Journal:  Lancet       Date:  2004-05-29       Impact factor: 79.321

2.  Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group.

Authors:  C M van der Horst; M S Saag; G A Cloud; R J Hamill; J R Graybill; J D Sobel; P C Johnson; C U Tuazon; T Kerkering; B L Moskovitz; W G Powderly; W E Dismukes
Journal:  N Engl J Med       Date:  1997-07-03       Impact factor: 91.245

3.  A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis. National Institute of Allergy and Infectious Diseases Mycoses Study Group.

Authors:  M S Saag; G A Cloud; J R Graybill; J D Sobel; C U Tuazon; P C Johnson; W J Fessel; B L Moskovitz; B Wiesinger; D Cosmatos; L Riser; C Thomas; R Hafner; W E Dismukes
Journal:  Clin Infect Dis       Date:  1999-02       Impact factor: 9.079

4.  Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america.

Authors:  John R Perfect; William E Dismukes; Francoise Dromer; David L Goldman; John R Graybill; Richard J Hamill; Thomas S Harrison; Robert A Larsen; Olivier Lortholary; Minh-Hong Nguyen; Peter G Pappas; William G Powderly; Nina Singh; Jack D Sobel; Tania C Sorrell
Journal:  Clin Infect Dis       Date:  2010-02-01       Impact factor: 9.079

5.  Comparison of the early fungicidal activity of high-dose fluconazole, voriconazole, and flucytosine as second-line drugs given in combination with amphotericin B for the treatment of HIV-associated cryptococcal meningitis.

Authors:  Angela Loyse; Douglas Wilson; Graeme Meintjes; Joseph N Jarvis; Tihana Bicanic; Leesa Bishop; Kevin Rebe; Anthony Williams; Shabbar Jaffar; Linda-Gail Bekker; Robin Wood; Thomas S Harrison
Journal:  Clin Infect Dis       Date:  2011-11-03       Impact factor: 9.079

6.  Fungal burden, early fungicidal activity, and outcome in cryptococcal meningitis in antiretroviral-naive or antiretroviral-experienced patients treated with amphotericin B or fluconazole.

Authors:  Tihana Bicanic; Graeme Meintjes; Robin Wood; Madeleine Hayes; Kevin Rebe; Linda-Gail Bekker; Thomas Harrison
Journal:  Clin Infect Dis       Date:  2007-05-25       Impact factor: 9.079

7.  Independent association between rate of clearance of infection and clinical outcome of HIV-associated cryptococcal meningitis: analysis of a combined cohort of 262 patients.

Authors:  Tihana Bicanic; Conrad Muzoora; Annemarie E Brouwer; Graeme Meintjes; Nicky Longley; Kabanda Taseera; Kevin Rebe; Angela Loyse; Joseph Jarvis; Linda-Gail Bekker; Robin Wood; Direk Limmathurotsakul; Wirongrong Chierakul; Kasia Stepniewska; Nicholas J White; Shabbar Jaffar; Thomas S Harrison
Journal:  Clin Infect Dis       Date:  2009-09-01       Impact factor: 9.079
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.